期刊文献+

血浆同型半胱氨酸水平与老年脑梗死的关系及药物干预研究 被引量:3

Investigation of the correlation between plasma homocysteine levels and cerebral infarction and the drug interventions in the elderly
原文传递
导出
摘要 目的探讨血浆同型半胱氨酸(HCY)的含量与老年脑梗死的关系及药物干预效果。方法选择2011年6月至2013年6月我院收治的老年脑梗死患者68例为脑梗死组,老年健康体检者38例为对照组。测定2组患者血浆HCY、叶酸、维生素B。血肌酐、空腹血糖、三酰甘油、胆固醇、收缩压、舒张压、身高、体质量等各指标的水平,并进行组间比较。同时做颈动脉彩色多普勒超声检查,比较脑梗死纽与对照组的颈动脉硬化情况及与HCY的关系。根据发作情况将脑梗死组分成初发组(32例)和复发组(36例),分别与对照组的HCY水平比较。同时,对脑梗死组患者给予叶酸及维生素B,:进行干预,比较前后HCY水平。结果(1)老年脑梗死患者血浆HCY水平高于对照组(P〈0.05),而血浆叶酸和维生素B】2水平均显著低于正常对照组(P〈0.05)。脑梗死组的血浆HCY水平与叶酸和维生素B12水平均呈负相关(P〈0.05)。Logistic回归分析显示HCY(OR=6.521,P〈0.05)是脑梗死的独立危险因素。(2)脑梗死复发组和初发组血浆HCY水平均显著高于对照组(P〈0.01),颈动脉内膜一中层厚度(IMT)均高于对照组(P〈0.05);脑梗死复发组血浆HCY水平高于初发组(P〈0.05),但2组间颈动脉IMT值差异无统计学意义。(3)对高HCY患者药物干预3—4周后血HCY显著降低(P〈0.01)。结论高HCY血症是老年脑梗死的一个重要危险因素;血浆HCY水平与颈动脉粥样硬化患者复发性脑梗死可能有关;给予叶酸、维生素B12干预可以有效降低血清HCY水平。 Objective To investigate the correlation between plasma homocysteine (HCY) level and cerebral infarc- tion in the elderly patients, and to investigate the drug interventions. Methods Sixty-eight elderly patients with ce-rebral infarction from June 2011 to June 2013 were collected as the experimental group and another 38 cases of healthy individuals were collected as the control group. Indicators including plasma levels of HCY, folic acid, vitamin B12, serum creatinine (SCR), fasting blood glucose (FBG), triglyceride (TG), total cholesterol (TC), systolic blood pressure (SBP), dias- tolic blood pressure (DBP), height, weight were detected and compared between two groups. Meanwhile, carotid Doppler uhrasonography detection was performed to analyze the correlation between the degree of carotid atherosclerosis and HCY levels within the two groups. Then the experimental group was further divided into primary group ( 32 patients) and recurrent group (36 patients) according to their episodic severity of cerebral infarctions, and the HCY levels were compared between these two groups and control group. And the HCY level in experimental group after drug interventions with folic acid and vi- tamin B12 was detected. Results (1) The plasma level of HCY in the experimental group was higher than that in the control group (P〈0.05), while the plasma levels of folate (P〈0. 05) and vitamin B12 (P〈0.05) were significantly lower than those in the control group. The plasma levels of HCY were negatively correlated with the levels of folic acid and vitamin B12 (P〈0.05). Logistic regression analysis showed that HCY level( OR= 6. 521, P〈O. 05) was an independent risk factor for cerebral infarction. (2) In both the recurrent group and primary group within the experimental group, plasma HCY level (P〈O. 01 ) and carotid IMT (P〈0. 05) were significantly higher than those in the control group; Plasma HCY level in the recurrent group was higher than that in the primary group (P〈O. 05), but the carotid IMT between the two groups showed no statistical significance. (3) In the patients with high plasma HCY level, the plasma HCY level significantly declined af-ter drug interventions for 3-4 weeks (P〈0. 01 ). Conclusions Hyperhomocysteinaemia is an important factor for cerebral infarction in the elderly. Plasma HCY level may be related to re-current cerebral infarctions in the patients with carotid atherosclerosis. Drug interventions with folic acid and vitamin B12 can effectively reduce the plasma HCY level.
作者 杨春华
出处 《实用老年医学》 CAS 2014年第4期290-293,共4页 Practical Geriatrics
关键词 同型半胱氨酸 脑梗死 颈动脉粥样硬化 叶酸 维生素B12 homocysteine cerebral infarction carotid atherosclerosis folic acid vitamin B12
  • 相关文献

参考文献12

  • 1樊东升.预防脑卒中要重视对高同型半胱氨酸水平的控制[J].中华老年医学杂志,2005,24(4):309-309. 被引量:25
  • 2Kittner SJ, Giles WH, Macko RF, et al. Homocysteine and risk of cerebral infarction in a biracial population : the stroke prevention in young woman study [ J]. Stroke, 1999,30 (8): 1554-1560.
  • 3Willinek WA, Ludwig M, Lennarz M, et al. High-normal serum homocysteine concentrations are associated with an in- creased risk of early atherosclerostic carotid artery wall lesions in healthy subjects [ J ]. J Hypertens, 2000, 18 (4) : 425-430.
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33091
  • 5Rothwell PM, Cou11 AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) [ J ] .Lancet,2005,366(9499) : 1773-1783.
  • 6Clarke R, Dalv L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease [ J ]. N Engl JMed, 1991,324(17) : 1149-1155.
  • 7Maline MR, Nieto FJ, Szklo M, et al. Carotid arery intimal- midial wall thickening and plasma homocysteineisymptomatic adults [ J ]. Circulation, 1993,87 (4) : 1107-1113.
  • 8Jeong SK, Seo JY, Cho YI.Homocysteine and internal carotid artery occlusion in ischemic stroke [ J ]. J Atheroscler Thromb, 2010,17 (9) :963 -969.
  • 9Sacco S,Carolei A.Homocysteine and stroke:another brick in the wall[ J] .Clin Sci(Lond) ,2009,118(3) : lS3-185.
  • 10刘伟,鲁广秀.血浆同型半胱氨酸水平与复发性脑梗死关系的相关性研究[J].中国实用神经疾病杂志,2011,14(4):17-19. 被引量:13

二级参考文献19

  • 1黄海威,郭明辉,黄家星,林锐金,张颖,陈亚利.1020名社区人群同型半胱氨酸水平的调查和相关分析[J].中华流行病学杂志,2006,27(8):721-724. 被引量:42
  • 2Moat SJ,Lang D,McDowell IF,et al.Folate,homocysteine,edothelial function and cardiovascular disease[J].J Nutr Biochem,2004,15:64-79.
  • 3Faraci FM,Lentz SR.Hyperhomocysteinnemia,oxidativestress,and cerebral dysfunction[J].Stroke,2004,35:345-347.
  • 4Malinow MR,Bostom AG,Newman CG,et al.Homocysteine,diet and cardiovascular diseases:a statements for healthcare professionals from the Nutrition Committee,American Heart Association[J].Circulation,1999,99:178-182.
  • 5Pezzini A,Del Zotto E,Padovani A.Homocysteine and cerebral ischemic:pathogenic and therapeutical implications[J].Curr Med Chem,2007,14(3):249-263.
  • 6Herrmann W.Significance of hyperhomocysteinnemia[J].Clin Lab,2006,52(7/8):367-374.
  • 7Boysen G,Brander T,Christensen H,et al.Homocysteine and risk of recurrent stroke[J].Stroke,2003,34:1 258-1 261.
  • 8Toole JF,Malinow MR,Chambless LE,et al.Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke,myocardial infarction,and death:the Vitamin Intervention for Stroke Prevention(VISP) randomized controlled trial[J].JAMA,2004,291:565-575.
  • 9Tantirittisak T,Sura T,Moleerergpoom W,et al.Plasma homocysteine and ischemic stroke patientsin Thailand[J].J Med Assoc Thai,2007,90(6):1 183-1 187.
  • 10Christopher R,Nagaraja SK.Homocysteine and cerebral stroke in developing countries[J].Curr Med Chem,2008,14(22):2 393-2 401.

共引文献33128

同被引文献37

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部